Boston Scientific (UK) Performance
| 0HOY Stock | 90.59 0.59 0.65% |
Boston Scientific has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.29, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Boston Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boston Scientific is expected to be smaller as well. Boston Scientific Corp right now shows a risk of 1.11%. Please confirm Boston Scientific Corp jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to decide if Boston Scientific Corp will be following its price patterns.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
1 | Boston Scientifics SWOT analysis medtech giants stock poised for growth - Investing.com | 12/03/2024 |
2 | Boston Scientific CMO Discuss Solutions for Health Inequality on Todays Marketplace - Quantisnow | 12/11/2024 |
| Begin Period Cash Flow | 1.1 B |
Boston |
Boston Scientific Relative Risk vs. Return Landscape
If you would invest 8,311 in Boston Scientific Corp on September 30, 2024 and sell it today you would earn a total of 748.00 from holding Boston Scientific Corp or generate 9.0% return on investment over 90 days. Boston Scientific Corp is generating 0.1387% of daily returns and assumes 1.1094% volatility on return distribution over the 90 days horizon. Simply put, 9% of stocks are less volatile than Boston, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Boston Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boston Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Boston Scientific Corp, and traders can use it to determine the average amount a Boston Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 0HOY | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.11 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Boston Scientific is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Boston Scientific by adding it to a well-diversified portfolio.
Boston Scientific Fundamentals Growth
Boston Stock prices reflect investors' perceptions of the future prospects and financial health of Boston Scientific, and Boston Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boston Stock performance.
| Return On Equity | 0.0892 | ||||
| Return On Asset | 0.049 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 142.62 B | ||||
| Shares Outstanding | 1.38 B | ||||
| Price To Sales | 7.90 X | ||||
| Revenue | 14.24 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.61 B | ||||
| Net Income | 1.59 B | ||||
| Total Debt | 9.57 B | ||||
| Book Value Per Share | 14.05 X | ||||
| Cash Flow From Operations | 2.5 B | ||||
| Earnings Per Share | 0.53 X | ||||
| Total Asset | 35.14 B | ||||
| Retained Earnings | 819 M | ||||
About Boston Scientific Performance
Assessing Boston Scientific's fundamental ratios provides investors with valuable insights into Boston Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Boston Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Boston Scientific is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Boston Scientific Corp performance evaluation
Checking the ongoing alerts about Boston Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boston Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 92.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Boston Scientific CMO Discuss Solutions for Health Inequality on Todays Marketplace - Quantisnow |
- Analyzing Boston Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boston Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Boston Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boston Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boston Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boston Scientific's stock. These opinions can provide insight into Boston Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.